Scientific letters
![](/images/Oa.jpg)
A phossphodiesterase inhibitor promotes the premature development of adverse cardiac remodelling mediated by beta-adrenergic activation in hypertension
Authors' affiliations
D Badenhorst, HMPG
C Anamourlis,
M Gibbs,
M Maseko,
O Osadchii,
A J Woodiwiss,
G R Norton,
Full Text
![](/images/icons/PDF.png)
Cite this article
Article History
Date published: 2008-08-27
Article Views
Full text views: 1386
Comments on this article
*Read our policy for posting comments here